Clinical Trials Market in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Patient Enrollment in Clinical Trials in Mexico

Clinical Trials Market in Mexico – Human Trials LATAM

The clinical trials market in Mexico has experienced significant growth in recent years, positioning the country as a prominent player in the global healthcare research landscape. With its well-established infrastructure, diverse patient population, favorable regulatory environment, and competitive costs, Mexico offers numerous advantages for conducting clinical trials.

This blog post aims to delve into the thriving clinical trials market in Mexico, exploring its key strengths, notable trends, regulatory framework, and future prospects. By understanding Mexico’s potential as a preferred destination for clinical trials, stakeholders can make informed decisions and leverage the country’s capabilities for advancing medical research.

The Rise of Mexico’s Clinical Trials Market

Mexico has emerged as a prime destination for clinical trials, witnessing a remarkable rise in activity over the past decade. Several factors contribute to this upward trajectory. Firstly, Mexico boasts a well-developed healthcare system with numerous prestigious research institutions and healthcare facilities.

This infrastructure provides access to a diverse patient pool, including a wide range of ethnicities, age groups, and disease prevalence. Moreover, the country’s proximity to the United States allows for easier collaboration and coordination with North American research organizations, facilitating streamlined clinical trial operations.

Additionally, Mexico offers competitive costs compared to other regions, making it an attractive option for sponsors seeking cost-effective research solutions. Lower expenses in areas such as labor, site operations, and regulatory compliance can significantly reduce the overall trial budget.

This cost advantage, combined with high-quality medical infrastructure, creates a compelling value proposition for pharmaceutical companies and contract research organizations (CROs) looking to conduct clinical trials.

Regulatory Framework and Ethical Considerations

Mexico has a well-defined regulatory framework for clinical trials, ensuring the protection of participants’ rights, data integrity, and ethical considerations. The Federal Commission for Protection against Sanitary Risk (COFEPRIS) governs clinical trial regulations in the country.

COFEPRIS aligns with international standards, including Good Clinical Practices (GCP), ensuring the reliability and validity of trial results.

The regulatory process for clinical trials in Mexico involves submission and approval of protocols, informed consent forms, investigational drug importation permits, and site inspections. COFEPRIS has implemented a simplified and efficient review system, which has expedited trial initiation timelines.

Furthermore, the Mexican government encourages transparency and collaboration among stakeholders, fostering an environment conducive to clinical research.

Ethical considerations play a pivotal role in clinical trials, and Mexico has a robust system in place to safeguard participants’ well-being. Institutional Review Boards (IRBs) oversee the ethical aspects of trials, ensuring that protocols meet stringent ethical standards.

The Mexican Association of Research Ethics Committees (AMCEI) provides guidance and supports the establishment and operation of IRBs, ensuring the highest ethical standards are maintained throughout the clinical trial process.

Clinical Trials Market in Mexico

Clinical Trials Market in Mexico

Clinical Trials Market in Mexico

Notable Trends and Opportunities

The clinical trials market in Mexico is witnessing several noteworthy trends, presenting exciting opportunities for sponsors and researchers alike. One such trend is the increasing focus on early-phase trials.

Mexico’s well-defined regulatory framework and diverse patient population make it an ideal location for conducting Phase I and Phase II trials, facilitating the evaluation of new compounds and therapies. This emphasis on early-phase trials has positioned Mexico as a vital contributor to global drug development efforts.

Another significant trend is the growing interest in specialized therapeutic areas. Mexico has seen a rise in clinical trials related to oncology, cardiovascular diseases, central nervous system disorders, and infectious diseases. This shift toward specialized research allows stakeholders to address specific medical needs, develop targeted therapies, and advance the understanding of diseases prevalent in the Mexican population.

Mexico’s emphasis on public-private collaborations is another notable trend. The government has been actively promoting partnerships between academic institutions, research centers, and industry players.

These collaborations facilitate knowledge exchange, resource sharing, and the development of joint research initiatives. Such partnerships not only enhance the quality and impact of clinical trials but also foster innovation and strengthen Mexico’s position as a hub for medical research.

Furthermore, Mexico’s large and diverse patient population presents a significant opportunity for conducting patient-centric clinical trials. Researchers can access a wide range of demographics, including different ethnicities, socioeconomic backgrounds, and disease prevalence, allowing for more representative and robust study results. This diversity enables sponsors to gather comprehensive data on drug efficacy, safety profiles, and potential variances in treatment responses.

The rise of digital technologies and telemedicine has also influenced the clinical trials landscape in Mexico. Virtual trials and remote monitoring offer several advantages, including increased patient enrollment, reduced travel and logistical burdens, and real-time data collection. These technologies have the potential to streamline trial operations, enhance patient engagement, and improve overall trial efficiency.

Challenges and Future Outlook

While the clinical trials market in Mexico presents numerous opportunities, it also faces certain challenges that need to be addressed. One key challenge is the need for greater public awareness and participation in clinical trials.

Educating the public about the importance of clinical research, addressing misconceptions, and building trust are essential for enhancing patient recruitment and retention rates.

Additionally, there is a need to further streamline and expedite regulatory processes to attract more international sponsors. Continued collaboration between regulatory bodies, industry stakeholders, and research institutions can contribute to creating a more efficient and predictable regulatory environment, further boosting Mexico’s competitiveness as a clinical trials destination.

Looking ahead, the future of the clinical trials market in Mexico appears promising. The country’s commitment to fostering a supportive research ecosystem, coupled with its strong healthcare infrastructure and diverse patient population, positions Mexico for continued growth and expansion in the field of clinical research.

With ongoing advancements in technology, increased public awareness, and further alignment with international standards, Mexico has the potential to become a global leader in clinical trials, attracting more investment, fostering innovation, and contributing to the development of life-saving therapies.


The clinical trials market in Mexico is experiencing a remarkable growth trajectory, driven by its well-developed infrastructure, diverse patient population, favorable regulatory environment, and competitive costs. Mexico’s strengths, coupled with the growing trends and opportunities, position the country as an attractive destination for conducting high-quality and impactful clinical research.

Clinical Trials Market in Mexico 

Source: Roche

Clinical Trials Market in Mexico

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Clinical Trials Market in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Clinical Trials Market in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Clinical Trials Market in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Clinical Trials Market in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Clinical Trials Market in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Clinical Trials Market in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Clinical Trials Market in Mexico

The Cohortias Team

Clinical Trials Market in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Clinical Trials Market in Mexico

Network & Partnerships